Cutler Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,800
Closed -$5K 5751
2022
Q2
$5K Sell
9,800
-83,400
-89% -$187K ﹤0.01% 3794
2022
Q1
$29K Buy
93,200
+89,500
+2,419% +$239K ﹤0.01% 2746
2021
Q4
$3K Sell
3,700
-11,800
-76% -$69K ﹤0.01% 4621
2021
Q3
$1K Buy
15,500
+7,400
+91% +$104K ﹤0.01% 5540
2021
Q2
$11K Buy
8,100
+1,700
+27% +$31K ﹤0.01% 3856
2021
Q1
$9K Sell
6,400
-6,500
-50% -$119K ﹤0.01% 3943
2020
Q4
$36K Buy
+12,900
New +$154K ﹤0.01% 2245

Other funds holding HGEN

Cutler Group's HGEN Position: Q1 2023 in Review

Cutler Group sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 5,239 shares.

Cutler Group first reported a position in HGEN in Q1 2021 and held it in 8 quarters. The position peaked at $454K in Q1 2022. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

  • Cutler Group reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,239 HUMANIGEN, INC. shares in Q1 2023.
  • Cutler Group first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 8 quarters.
  • Cutler Group's HUMANIGEN, INC. position peaked at $454K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.